Tower Research Capital LLC (Trc) Bio Affinity Technologies, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,332 shares of BIAF stock, worth $5,255. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,332
Previous 2,085
203.69%
Holding current value
$5,255
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BIAF
# of Institutions
17Shares Held
536KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA261KShares$216,5210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.6KShares$82,6270.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC46.3KShares$38,4320.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$23,1440.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$14,6080.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $2.26M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...